GRANULES INDIA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Granules India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
1.38₹ 7.3
As on Sep 12, 2025, 4:01 PM IST
Granules India Price Performance
Today's LowToday's High
₹522.95₹536.20
₹534.45
52 Weeks' Low52 Weeks' High
₹412.05₹690.00
₹534.45
Open Price
₹529.85
Prev. Close
₹527.15
Volume
88,961
Over the last 5 years, the share price of Granules India has gained 7.55% CAGR. Over the past year, the corresponding return has been -5.37%.
Granules India’s current P/E of 27.05x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Granules India Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Granules India | 4.60 | 17.40 | 2.02 | 12.33 | -5.37 | 20.24 | 7.55 |
| Sun Pharmaceutical Industries | 0.97 | -0.73 | -4.56 | -3.95 | -13.67 | 21.98 | 26.56 |
| Divi's Laboratories | 0.07 | 0.88 | -10.55 | 6.14 | 9.71 | 17.82 | 13.69 |
| Cipla | 1.32 | 3.49 | 4.77 | 8.25 | -5.03 | 13.91 | 16.87 |
| Torrent Pharmaceuticals | -0.56 | -1.88 | 9.19 | 14.98 | 2.90 | 33.17 | 20.55 |
| Dr. Reddy's Laboratories | 3.77 | 7.85 | -3.43 | 19.10 | -1.52 | 15.58 | 8.56 |
| Mankind Pharma | 1.25 | 6.28 | 8.24 | 19.09 | 6.23 | 21.96 | 12.65 |
| Zydus Lifesciences | 3.03 | 9.28 | 6.77 | 17.53 | -6.72 | 40.52 | 23.17 |
| Lupin | 5.05 | 5.10 | 1.03 | 3.96 | -9.07 | 44.90 | 16.11 |
| Abbott India | -0.30 | -3.89 | -1.24 | 4.23 | 4.63 | 19.70 | 13.47 |
| Alkem Laboratories | 1.96 | 5.64 | 12.31 | 14.54 | -14.27 | 19.30 | 13.34 |
| Aurobindo Pharma | 4.78 | 3.43 | -5.26 | -1.14 | -29.86 | 25.70 | 6.59 |
| Glenmark Pharmaceuticals | 3.46 | 3.29 | 29.73 | 49.52 | 21.55 | 75.97 | 34.52 |
| Biocon | 0.26 | 2.78 | 3.50 | 12.23 | -3.13 | 6.33 | -3.24 |
| Laurus Labs | 1.70 | 7.84 | 34.48 | 53.36 | 76.74 | 17.90 | 27.44 |
| GlaxoSmithKline Pharmaceuticals | 0.17 | 7.18 | -16.38 | 3.45 | -3.04 | 24.98 | 9.94 |
| Anthem Biosciences | 0.28 | 11.92 | 13.93 | 13.93 | 13.93 | 4.44 | 2.64 |
| Cohance Lifesciences | 5.60 | 2.61 | -3.08 | -15.81 | -17.91 | 26.94 | 21.87 |
| Ipca Laboratories | -1.62 | -4.55 | -5.03 | -0.24 | -9.78 | 14.50 | 4.09 |
| Gland Pharma | 6.68 | 4.84 | 21.20 | 28.02 | 6.91 | -5.10 | 2.10 |
Over the last one year, Granules India has declined 5.37% compared to peers like Sun Pharmaceutical Industries (-13.67%), Divi's Laboratories (9.71%), Cipla (-5.03%). From a 5 year perspective, Granules India has underperformed peers relative to Sun Pharmaceutical Industries (26.56%) and Divi's Laboratories (13.69%).
Granules India Financials
Granules India Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 518.63 | 521.68 |
| 10 | 509.35 | 511.9 |
| 20 | 484.9 | 497.54 |
| 50 | 479.4 | 487.61 |
| 100 | 488 | 491.89 |
| 200 | 515.26 | 501.68 |
Granules India Share Holding Pattern
In the latest quarter, Granules India saw a rise in promoter holding to 40.28%, while DII stake increased to 23.52%, FII holding fell to 13.24%, and public shareholding moved up to 24.41% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Granules India Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| Aditya Birla Sun Life Pure Value Fund | 26,64,920 | 2.08 | 126.56 |
| Edelweiss Balanced Advantage Fund | 22,09,668 | 0.82 | 104.94 |
| Axis Multicap Fund | 16,45,461 | 0.94 | 78.14 |
| ICICI Prudential Equity - Arbitrage Fund | 13,40,525 | 0.2 | 63.66 |
| Axis Midcap Fund | 11,18,865 | 0.17 | 53.13 |
| Aditya Birla Sun Life Small Cap Fund | 11,06,670 | 1.05 | 52.56 |
| Tata Hybrid Equity Fund - Regular Plan | 11,00,000 | 1.28 | 52.24 |
| Axis Growth Opportunities Fund | 10,63,974 | 0.34 | 50.53 |
| SBI Arbitrage Opportunities Fund | 10,53,500 | 0.13 | 50.03 |
| Invesco India Arbitrage Fund | 10,42,750 | 0.2 | 49.52 |
Granules India Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Granules India Options
Granules India Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 04, 2025, 4:55 PM IST | Granules India L - Announcement under Regulation 30 (LODR)-Allotment |
| Aug 19, 2025, 5:34 AM IST | Granules India L - Transcript Of Earning Conference Call For Q1 Of FY26 |
| Aug 12, 2025, 10:25 PM IST | Granules India L - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Aug 12, 2025, 6:40 PM IST | Granules India L - Announcement under Regulation 30 (LODR)-Investor Presentation |
| Aug 12, 2025, 6:37 PM IST | Granules India L - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Granules India
Granules India Ltd. is a Public Limited Listed company incorporated on 18/03/1991 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1991PLC012471 and registration number is 012471. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 3030.16 Cr. and Equity Capital is Rs. 24.25 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address15th Floor, Granules Tower, Botanical Garden Road, Hyderabad Telangana 500084
- Contact
Management
- Dr. Krishna Prasad ChigurupatiChairman & Managing Director
- Dr. K V S Ram RaoJoint Managing Director & CEO
- Mr. Harsha ChigurupatiNon Ind.& Exe.Director
- Mrs. Uma Devi ChigurupatiNon Ind.& Exe.Director
- Mr. Kolli Basava Sankar RaoNon Exe.Non Ind.Director
- Dr. Saumen ChakrabortyInd. Non-Executive Director
- Mrs. Sucharita Rao PalepuInd. Non-Executive Director
- Dr. Sethurathnam RaviInd. Non-Executive Director
- Mr. Arun SawhneyInd. Non-Executive Director
- Mr. Kapil Kumar MehanInd. Non-Executive Director
- Mrs. Priyanka ChigurupatiNon Ind.& Exe.Director
- Mr. Rajiv Pritidas KakodkarInd. Non-Executive Director
FAQs on Granules India Share Price
What is the share price of Granules India?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Granules India is ₹534.45 as on Sep 12, 2025.
What kind of stock is Granules India?
The Granules India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Granules India?
The market cap of Granules India is ₹12,969.43 Cr as on Sep 12, 2025.
What are today's High and Low prices of Granules India?
Today’s highest and lowest price of Granules India are ₹536.20 and ₹522.95.
What are the 52 Week High and 52 Week Low of Granules India?
The 52-week high/low is the highest and lowest price at which Granules India stock has traded in the past 52-week or nearly a year. The 52-week high of Granules India is ₹690.00 and 52-week low of Granules India is ₹412.05 as on Sep 12, 2025.
How has the Granules India performed historically in terms of returns?
The Granules India has shown returns of 1.38% over the past day, 17.4% for the past month, 2.02% over 3 months, -5.37% over 1 year, 20.24% across 3 years, and 7.55% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Granules India?
P/E ratio of and PB ratio of Granules India are 27.05 and 3.78 on Sep 12, 2025. While the company gives a dividend yield of 0.28 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data